Genesco Inc. Files Q3 2024 10-Q Report
Ticker: GCO · Form: 10-Q · Filed: Dec 12, 2024 · CIK: 18498
Sentiment: neutral
Topics: 10-Q, quarterly-report, retail, footwear
TL;DR
Genesco's Q3 2025 10-Q is in, check the numbers for Journeys, Schuh, and J&M.
AI Summary
Genesco Inc. reported its third-quarter results for the period ending November 2, 2024. The company's fiscal year ends on February 1st. Key segments include Genesco Brands, Schuh Group, Johnston & Murphy Group, and Journeys Group. The filing also references financial data from January 28, 2023, and October 28, 2023.
Why It Matters
This 10-Q filing provides investors with an update on Genesco's financial performance and operational segments for the third quarter of fiscal year 2025, offering insights into the company's current business standing.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediately apparent significant negative events.
Key Players & Entities
- Genesco Inc. (company) — Filer of the 10-Q report
- 2024-11-02 (date) — End of the reporting period for the 10-Q
- 2025-02-01 (date) — Fiscal year end for Genesco Inc.
- Genesco Brands (company) — Operating segment
- Schuh Group (company) — Operating segment
- Johnston & Murphy Group (company) — Operating segment
- Journeys Group (company) — Operating segment
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the third quarter, ending on November 2, 2024.
When does Genesco Inc.'s fiscal year end?
Genesco Inc.'s fiscal year ends on February 1st.
Which operating segments are mentioned in the filing?
The filing mentions Genesco Brands Segment, Schuh Group Segment, Johnston & Murphy Group Segment, and Journeys Group Segment.
What is the filing date of this 10-Q report?
This 10-Q report was filed on December 12, 2024.
What is Genesco Inc.'s Standard Industrial Classification code?
Genesco Inc.'s Standard Industrial Classification code is 5661, which corresponds to Retail - Shoe Stores.
Filing Stats: 4,575 words · 18 min read · ~15 pages · Grade level 14 · Accepted 2024-12-12 10:53:07
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value GCO New York Stock Exchan
Filing Documents
- gco-20241102.htm (10-Q) — 1990KB
- gco-ex31_1.htm (EX-31.1) — 9KB
- gco-ex31_2.htm (EX-31.2) — 9KB
- gco-ex32_1.htm (EX-32.1) — 6KB
- gco-ex32_2.htm (EX-32.2) — 6KB
- 0000950170-24-135629.txt ( ) — 7026KB
- gco-20241102.xsd (EX-101.SCH) — 734KB
- gco-20241102_htm.xml (XML) — 1400KB
Financial Information
Part I. Financial Information
Financial Statements
Item 1. Financial Statements: Condensed Consolidated Balance Sheets - November 2, 2024, February 3, 2024 and October 28, 2023 4 Condensed Consolidated Statements of Operations - Three and Nine Months ended November 2, 2024 and October 28, 2023 5 Condensed Consolidated Statements of Comprehensive Income (Loss) - Three and Nine Months ended November 2, 2024 and October 28, 2023 6 Condensed Consolidated Statements of Cash Flows - Nine Months ended November 2, 2024 and October 28, 2023 7 Condensed Consolidated Statements of Equity - Three and Nine Months ended November 2, 2024 and October 28, 2023 8 Notes to Condensed Consolidated Financial Statements 9
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 15
Quantitative and Qualitative Disclosures about Market Risk
Item 3. Quantitative and Qualitative Disclosures about Market Risk 23
Controls and Procedures
Item 4. Controls and Procedures 23
Other Information
Part II. Other Information 24
Legal Proceedings
Item 1. Legal Proceedings 24
Risk Factors
Item 1A. Risk Factors 24
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 24
Other Information
Item 5. Other Information 24
Exhibits
Item 6. Exhibits 25
Signatures
Signatures 26 2 cautionary notice regarding forward-looking statements
- FINANC IAL INFORMATION
PART I - FINANC IAL INFORMATION
Financial Sta tements (unaudited)
Item 1. Financial Sta tements (unaudited) Genesco Inc. and Subsidiaries Condensed Consolida ted Balance Sheets (In thousands, except share amounts) Assets November 2, 2024 February 3, 2024 October 28, 2023 Current Assets: Cash $ 33,578 $ 35,155 $ 21,691 Accounts receivable, net of allowances of $ 2,591 at November 2, 2024, $ 4,266 at February 3, 2024 and $ 4,836 at October 28, 2023 52,373 53,618 56,934 Inventories 523,152 378,967 516,735 Prepaids and other current assets 50,600 39,611 43,350 Total current assets 659,703 507,351 638,710 Property and equipment, net 230,090 240,266 245,009 Operating lease right of use assets 424,886 436,896 459,524 Non-current prepaid income taxes 58,670 56,839 55,632 Goodwill 9,230 9,565 9,283 Other intangibles 27,214 27,250 26,442 Deferred income taxes 339 26,230 33,163 Other noncurrent assets 25,389 25,493 25,168 Total Assets 1,435,521 1,329,890 1,492,931 Liabilities and Equity Current Liabilities: Accounts payable 214,935 114,621 186,683 Current portion - operating lease liabilities 123,397 129,189 134,850 Other accrued liabilities 83,750 75,727 75,631 Total current liabilities 422,082 319,537 397,164 Long-term debt 100,114 34,682 128,163 Long-term operating lease liabilities 348,672 359,073 387,347 Other long-term liabilities 47,749 45,396 43,299 Total liabilities 918,617 758,688 955,973 Commitments and contingent liabilities — — — Equity Non-redeemable preferred stock 823 813 812 Common equity: Common stock, $ 1 par value: Authorized: 80,000,000 shares Issued common stock 11,701 11,961 11,991 Additional paid-in capital 328,760 319,143 316,206 Retained earnings 231,997 296,766 269,576 Accumulated other comprehensive loss ( 38,520 ) ( 39,624 ) ( 43,770 ) Treasury shares, at co